Moderate systemic hypotension during reperfusion reduces the coronary blood flow and increases the size of myocardial infarction in pigs

Chest

Volumn 125, Issue 4, 2004, Pages 1492-1499

  Nanas, John N ^a,b   Tsolakis, Elias ^a   Terrovitis, John V ^a   Eleftheriou, Ageliki ^a   Drakos, Stavros G ^a   Dalianis, Argirios ^a   Charitos, Christos E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Blood flow; BP; Collateral circulation; Infarction; Reperfusion

Indexed keywords

GLYCERYL TRINITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY PRESSURE; FLOW MEASUREMENT; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEMODYNAMICS; HYPOTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; REPERFUSION; SWINE;

EID: 16544363165     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.4.1492     Document Type: Article

References (36)

1. Dellsperger KC, Clothier JL, Hartnett JA, et al. Acceleration of the wavefront of myocardial necrosis by chronic hypertension and left ventricular hypertrophy in dogs. Circ Res 1988; 63:87-96
2. Inou T, Lamberth WC Jr, Koyanagi S, et al. Relative importance of hypertension after coronary occlusion in chronic hypertensive dogs with LVH. Am J Physiol 1987; 253:H1148-H1158
3. Lee KL, Woodlief LH, Topol EJ, et al, for the GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41021 patients. Circulation 1995; 91:1659-1668
4. 2, on myocardial infarct size after coronary occlusion in conscious dogs. Circ Res 1981; 49:685-700
5. Simpson PJ, Mickelson J, Fantone JC, et al. Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart. Circ Res 1987; 60:666-673
6. Simpson PJ, Mitsos SE, Ventura A, et al. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J 1987; 113:129-137
7. 1: inhibition of neutrophil migration and activation. J Pharmacol Exp Ther 1988; 244:619-624
8. de Lorgeril M, Ovize M, Delaye J, et al. Importance of the flow perfusion deficit in the response to captopril in experimental myocardial infarction. J Cardiovasc Pharmacol 1992; 19:324-329
9. Fukuyama T, Schechtman KB, Roberts R. The effects of intravenous nitroglycerin on hemodynamics, coronary blood flow and morphologically and enzymatically estimated infarct size in conscious dogs. Circulation 1980; 62:1227-1238
10. Jugdutt BI. Myocardial salvage by intravenous nitroglycerin in conscious dogs: loss of beneficial effect with marked nitroglycerin-induced hypotension. Circulation 1983; 68:673-684
11. Warltier DC, Gross GJ, Brooks HL. Pharmacologic- vs. ischemia-induced coronary artery vasodilation. Am J Physiol 1981; 240:H767-H774
12. Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981; 101:593-600
13. Nanas JN, Nanas SN, Kontoyannis DA, et al. Myocardial salvage by the use of reperfusion and intraaortic balloon pump: experimental study. Ann Thorac Surg 1996; 61:629-634
14. Pantely GA, Ladley HD, Bristow JD. Low zero-flow pressure and minimal capacitance effect on diastolic coronary arterial pressure-flow relationships during maximum vasodilation in swine. Circulation 1984; 70:485-494
15. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343:1115-1122
16. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995; 345:669-685
17. Toyoda Y, Di Gregorio V, Parker RA, et al. Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning. Circulation 2000; 102:III326-III338
18. Olafsson B, Forman MB, Puett DW, et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 1987; 76:1135-1145
19. Muraki S, Morris CD, Budde JM, et al. Experimental off-pump coronary artery revascularization with adenosine: enhanced reperfusion. J Thorac Cardiovasc Surg 2001; 121:570-579
20. Marzilli M, Orsini E, Marraccini P, et al. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000; 101:2154-2159
21. Waller BF, Rothbaum DA, Pinkerton CA, et al. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy. J Am Coll Cardiol 1987; 9:785-801
22. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002; 105:656-662
23. Kloner RA, Canote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54:1496-1508
24. Tranum-Jensen J, Janse MJ, Fiolet JWT, et al. Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine heart. Circ Res 1981; 49:364-381
25. Humphrey SM, Gavin JB, Herdson PB. The relationship of ischemic contracture of vascular reperfusion in the isolated rat heart. J Mol Cell Cardiol 1980; 12:1397-1406
26. Kloner RA, Rude RE, Carlson N, et al. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation 1980; 62:945-952
27. Kelly RF, Hursey TL, Schaer GL, et al. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion. J Investig Med 1996; 44:575-582
28. Barros LF, Coelho IJ, Petrini CA, et al. Myocardial reperfusion:leukocyte accumulation in the ischemic and remote non-ischemic regions. Shock 2000; 13:67-71
29. Kingma JG Jr, Plante S, Bogaty P. Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion. J Am Coll Cardiol 2000; 36:2317-2324
30. Johnson WB, Malone SA, Pantely GA, et al. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation 1988; 78:462-472
31. Cobb FR, Bache RJ, Rivas F, et al. Local effects of acute cellular injury on regional myocardial blood flow. J Clin Invest 1976; 57:1359-1368
32. Reffelmann T, Hale SL, Li G, et al. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol 2002; 282:H766-H772
33. Ritter LS, McDonagh PF. Low-flow reperfusion after myocardial ischemia enhances leucocyte accumulation in coronary microcirculation. Am J Physiol 1997; 273:H1154-H1165
34. Ambrosio G, Weisman HF, Mannisi JA, et al. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989; 80:1846-1861
35. Smalling RW, Cassidy DB, Barrett R, et al. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. Circulation 1992; 85:1152-1159
36. Ohman EM, Nanas J, Stomel R, et al. Thrombolysis and counterpulsation to improve cardiogenic shock survival (TACTICS) [abstract]: results of a prospective randomized trial. Circulation 2000; 102:II-600